Pharmaceutical Executive

Pharmaceutical Executive-05-01-2013
Volume: 0
Issue: 0

Pharmaceutical Executive-04-01-2013
Volume: 0
Issue: 0

Pharmaceutical Executive-03-01-2013
Volume: 0
Issue: 0

Pharmaceutical Executive-02-01-2013
Volume: 0
Issue: 0

Pharmaceutical Executive-01-01-2013
Volume: 0
Issue: 0

Pharmaceutical Executive-12-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-11-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-10-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-09-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-08-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-07-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-06-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-05-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-04-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-03-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-02-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-01-01-2012
Volume: 0
Issue: 0

Pharmaceutical Executive-12-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-11-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-10-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-09-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-08-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-07-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-06-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-05-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-04-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-03-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-02-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-01-01-2011
Volume: 0
Issue: 0

Pharmaceutical Executive-12-01-2010
Volume: 0
Issue: 0
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
2
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
3
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
4
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
5
